A systematic review and meta-analysis of MDM2 polymorphisms in osteosarcoma susceptibility

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pediatric Research

• Publication date

  2016-06-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/pr.2016.120PMID 27438225
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Homologous Recombination Repair Polymorphisms and the Risk for Osteosarcoma

  2015cited by this paper
• Letter regarding Wang et al. entitled “Effects of murine double minute 2 polymorphisms on the risk and survival of osteosarcoma: a systemic review and meta-analysis”

  2014cited by this paper
• Letter regarding Wang et al. entitled “Effects of murine double minute 2 polymorphisms on the risk and survival of osteosarcoma: a systematic review and meta-analysis”

  2014cited by this paper
• Association of two polymorphisms rs2910164 in miRNA-146a and rs3746444 in miRNA-499 with rheumatoid arthritis: a meta-analysis.

  2014cited by this paper
• Effects of murine double minute 2 polymorphisms on the risk and survival of osteosarcoma: a systemic review and meta-analysis

  2014cited by this paper
• Integrative Algorithms in Patient Focused Laboratory Medicine

  2013cited by this paper
• Genome-wide Association Study Identifies Two Susceptibility Loci for Osteosarcoma

  2013cited by this paper
• Association analysis between genetic variants of MDM2 gene and osteosarcoma susceptibility in Chinese.

  2013cited by this paper
• A Genetic Variant in miR-196a2 Increased Digestive System Cancer Risks: A Meta-Analysis of 15 Case-Control Studies

  2012cited by this paper
• Association of FGFR3 and MDM2 Gene Nucleotide Polymorphisms with Bone Tumors

  2012influential reference
• Primary malignant bone tumors--recent developments.

  2011cited by this paper
• MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk

  2011cited by this paper
• Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death

  2011cited by this paper
• A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma

  2011influential reference
• Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and MDM2 Amplification in Sarcomagenesis

  2010influential reference
• Effect of TP53 Arg72Pro and MDM2 SNP309 Polymorphisms on the Risk of High-Grade Osteosarcoma Development and Survival

  2009influential reference
• Germ‐line genetic variation of TP53 in osteosarcoma

  2007cited by this paper
• Analysis of Polymorphisms of the Vitamin D Receptor, Estrogen Receptor, and Collagen I&agr;1 Genes and Their Relationship With Height in Children With Bone Cancer

  2003cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper

• Genetic susceptibility to retinoblastoma: A meta-analysis of single-nucleotide polymorphisms across global populations.

  2025cites this paper
• Interfering with UBE2L3 expression targets regulation of MLKL to promote necroptosis inhibition of growth in osteosarcoma

  2025cites this paper
• Genetic variants associated with osteosarcoma risk: a systematic review and meta-analysis

  2024cites this paper
• NELL-1 regulates the matrisome to alter osteosarcoma disease progression

  2022cites this paper
• NELL-1 regulates the matrisome to promote osteosarcoma progression.

  2022cites this paper
• The effects of common variants in MDM2 and GNRH2 genes on the risk and survival of osteosarcoma in Han populations from Northwest China

  2020cites this paper
• Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact

  2020cites this paper
• Classifying Osteosarcoma Using Meta-Analysis of Gene Expression

  2018cites this paper
• miR-27a-3p promotes the malignant phenotypes of osteosarcoma by targeting ten-eleven translocation 1.

  2018cites this paper
• Genetic susceptibility to bone and soft tissue sarcomas: a field synopsis and meta-analysis

  2018cites this paper
• Systematic meta-analysis of genetic variants associated with osteosarcoma susceptibility

  2018cites this paper
• Bone morphogenetic protein and activin membrane-bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF-β-induced EMT signaling pathway

  2018cites this paper
• Association between MDM2 rs2279744, MDM2 rs937283, and p21 rs1801270 polymorphisms and retinoblastoma susceptibility

  2018cites this paper
• Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway

  2018cites this paper
• Combined analysis of gene expression, miRNA expression and DNA methylation profiles of osteosarcoma.

  2017cites this paper